Underwriters Sell More Shares in an IPO Than the Company Issues
The overallotment option lets banks sell up to fifteen percent more stock than exists, leaving them short. How they cover that short position is what stabilises the price after listing.
The Arrangement
In a public offering the underwriters typically have an overallotment option, commonly called a greenshoe, allowing them to buy additional shares from the company at the offer price, usually up to fifteen percent more than the base deal.
The important part is the sequence. The underwriters sell the extra shares to investors first, before deciding whether to exercise the option. Having sold shares they do not yet own, they are short.
Why Being Short Is the Point
That short position gives the underwriters a tool, and which way they use it depends on what the stock does.
If the price rises above the offer price, they exercise the option, buy the shares from the company at the offer price, and deliver them to the investors they sold to. The short is covered at no cost, the company sells more shares, and everyone is satisfied.
If the price falls below the offer price, they do not exercise. Instead they buy shares in the open market to cover the short. That buying is real demand appearing exactly when the stock is weak, which supports the price.
The bank ends up buying when the stock falls and not buying when it rises, which is precisely the behaviour that stabilises a new listing. The short position is what funds it.
Why This Is Permitted
Buying a security to support its price would ordinarily raise serious market manipulation concerns. This is explicitly permitted, within defined limits, because a newly listed stock has no trading history and a disorderly first few days serves nobody.
The activity is bounded: it is disclosed in the prospectus, capped at the size of the option, limited to a defined period, and cannot be conducted above the offer price. Those constraints are what separate stabilisation from manipulation.
| Outcome | Underwriter action | Effect |
|---|---|---|
| Stock trades up | Exercise the option | Company sells more shares |
| Stock trades down | Buy in the market to cover | Supports the price |
What It Signals
Whether the option was exercised is disclosed and is informative. Full exercise indicates the deal was well received and traded above the offer price. No exercise indicates the underwriters were supporting a weak stock.
It is one of the few clean signals available about how a listing actually went, as distinct from how it was described.
The Limits
Stabilisation is bounded in size and time, and it cannot rescue a badly priced deal. The option covers fifteen percent of the offering, and once that capacity is used the support stops.
This is why some listings fall steadily after the stabilisation period ends. The support was masking an imbalance rather than correcting it, and when it is withdrawn the price finds its own level. Anyone reading price behaviour in the first weeks after a listing should know whether stabilisation is still active.
Why the Company Accepts It
From the company perspective this is close to free. If the stock does well, it sells more shares at the offer price, which is dilution it agreed to in advance. If the stock does badly, it gets price support it did not pay for directly.
The cost is embedded in underwriting fees and in the pricing of the deal itself. There is a long standing argument that offerings are deliberately underpriced, transferring value from the company to the investors who receive allocations, and the stabilisation machinery sits inside that broader debate rather than outside it.
The Bottom Line
Underwriters oversell a new offering on purpose, creating a short position they cover either by buying shares from the company at the offer price or by buying in the market. That structure makes them a buyer when the stock is weak and a non buyer when it is strong. It is disclosed, bounded, and it is why the first days of trading in a new listing are not a free market in the ordinary sense.